Results 331 to 340 of about 6,006,073 (362)

XAI in Drug Discovery

[No abstract available]
openaire   +2 more sources

Anti-trypanosomatid drug discovery: progress and challenges

Nature Reviews Microbiology, 2022
David Horn, Susan Wyllie, Manu De Rycker   +2 more
exaly  

GPCR drug discovery: new agents, targets and indications

Nature reviews. Drug discovery
Javier Sánchez Lorente, Aleksandr V. Sokolov, Gavin Ferguson, H. Schiöth, A. S. Hauser, David E. Gloriam   +5 more
semanticscholar   +1 more source

Machine learning in preclinical drug discovery

Nature Chemical Biology
Denise B. Catacutan, Jeremie Alexander, Autumn Arnold, Jonathan M. Stokes   +3 more
semanticscholar   +1 more source

The emerging role of mass spectrometry-based proteomics in drug discovery

Nature reviews. Drug discovery, 2022
F. Meissner, Jennifer Geddes-McAlister, Matthias Mann, M. Bantscheff   +3 more
semanticscholar   +1 more source

Drug Discovery in Czechia

Journal of Medicinal Chemistry
Pavla Perlíková, Ondřej Baszczyňski
openaire   +2 more sources

Opportunities and challenges in phenotypic drug discovery: an industry perspective

Nature Reviews Drug Discovery, 2017
Marco Prunotto, Fabien Vincent, Jonathan A Lee   +2 more
exaly  

The 'rule of three' for fragment-based drug discovery: where are we now?

Nature Reviews Drug Discovery, 2013
Harren Jhoti, Chris Murray, Murray Christopher W   +2 more
exaly  

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

, 1997
C. Lipinski, F. Lombardo, B. Dominy, P. Feeney   +3 more
semanticscholar   +1 more source

Mitigating risk in academic preclinical drug discovery

Nature Reviews Drug Discovery, 2015
Michael A Walters, James Inglese, Jayme L Dahlin   +2 more
exaly